UBS Group’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$348 Buy
2024
Q2
Sell
2024
Q1
$2.48K Buy
2023
Q4
$141 Buy
2023
Q3
Sell
2023
Q2
$101 Sell
2023
Q1
$1.15K Buy
2022
Q4
Sell
2022
Q3
$31K Buy
2022
Q2
Sell
2022
Q1
$7K Sell
2021
Q4
$9K Buy
2020
Q2
Sell
2020
Q1
$20K Sell
2019
Q4
$34K Buy